The Department of Health and Social Care (DHSC) has extended a medicine supply notification for H2-antagonists including Cimetidine, Famotidine, and Nizatidine.
The resupply dates of the products are now expected on the following dates.
| Product | Supplier | Anticipated Resupply date | Detail |
| Famotidine 20mg tablets | Tilomed Laboratories | mid – August 2020 | |
| Teva UK | mid – August 2020 | ||
| Famotidine 40mg tablets | Tilomed Laboratories | end- August 2020 | |
| Teva UK | in stock | ||
| Cimetidine 200mg tablets | Ennogen Pharma | June 2021 | Unlicensed supplies have been sourced |
| Medreich | to be confirmed | ||
| Cimetidine 400mg tablets | Ennogen Pharma | June 2021 | |
| Medreich | to be confirmed | ||
| Cimetidine 800mg tablets | Ennogen Pharma | June 2021 | |
| Medreich | to be confirmed | ||
| Cimetidine 200mg/5ml oral solution | Rosemont Pharmaceuticals | n/a | In stock |
| Nizatidine 150mg tablets | Mylan | in stock | |
| Medreich | to be confirmed | ||
| Relonchem | end – August 2020 | ||
| Nizatidine 300mg tablets | Mylan | In stock | |
| Medreich | to be confirmed | ||
| Relonchem | end – August 2020 |
The following specialist importers have confirmed they can source unlicensed cimetidine tablets.
- Alium Medical (200mg, 400mg and 800mg)
- Mawdsley’s Unlicensed (400mg)
